Project Grant R21TR005231

Award Date 8/1/24
Completion Date 7/31/26
Dollars Obligated $451K
Federal Grant Program
93.350
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92093, USA
Similar Awards
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), will fund the development of novel artificial muscle-driven robotic eyes to study the biomechanics of human eye movement and improve understanding of conditions like strabismus. The $296,927 award to George Mason University aims to: (1) establish a computational model to...
This federal Project Grant award, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to engineer a miniaturized ultra-widefield micro-camera array microscope (MCAM) capable of imaging a large area of the cerebellar cortex with cellular resolution in freely behaving mice. The $183,751 award, with a project period from April 1, 2025 to March 31, 2027, will...
This Project Grant award of $208,888.00 from the National Institute of Mental Health (CFDA 93.242 - Mental Health Research Grants) supports research to develop computer vision techniques for identifying autism spectrum disorder (ASD) motor deficits in infants. The Washington University project aims to leverage deep learning and computational ethology to automatically extract and analyze kinematic data from video assessments of infant behavior, with the goal of creating objective, scalable...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $234,276 over 5 years to the University of California, San Diego (UCSD) to conduct research on predicting outcomes for epilepsy surgery. The project aims to use functional MRI (fMRI) and advanced statistical/machine learning methods to identify associations between brain network...
This U19 Cooperative Agreement award, funded by the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867), supports a multidisciplinary research project focused on understanding the neuronal circuits in the brainstem that coordinate orofacial motor actions, such as breathing, feeding, sniffing, and whisking. The $642,536 award supports a team of researchers at the University of California, San Diego (UCSD) to investigate the high-level and low-level computations underlying...
This Project Grant award of $455,371 from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), is funding the development and validation of a novel microchip-based platform for the discovery and characterization of migraine therapies. The key products and services to be delivered under this award include: Quantifying comprehensive neurovascular and behavioral responses to established migraine triggers and...
This Project Grant award, with ID F32NS140212, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The $146,816 award supports research to simultaneously measure synaptic and spiking activity in corticospinal projection neurons in the primary motor cortex during the learning of a skilled motor task. The University of California, San Diego...
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD) under CFDA Program 93.173 - Research Related to Deafness and Communication Disorders, will fund research to investigate sensorimotor mechanisms underlying speech fluency in individuals who stutter. The $464,268 award, with a project period from September 1, 2024 to August 31, 2026, will be provided to the Regents of the University of California, San Francisco (UCSF) to conduct...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $272,000.00 to support a Clinical Trials Methodology Course in Neurological Disorders (CTMC). The goal of this training program is to supply the healthcare system with effective clinical researchers and biostatisticians capable of implementing well-designed clinical...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $273,254 to the University of California, San Diego (UCSD) to conduct research on the neural computations involved in active sensing, particularly focused on the sense of touch through vibrissa movement in mice. The 4-year project aims to develop theoretical models and...

This federal Project Grant award from the National Center for Advancing Translational Sciences (CFDA 93.350) will support a $450,836 research project at the University of California, San Diego (UCSD) to develop and validate a Computational Motor Objective Rater (CMOR) system for quantifying motor symptoms in patients with blepharospasm, a form of focal dystonia.

The key objectives are to: 1) Evaluate the CMOR system's convergent validity with patient-reported severity of facial spasms and excessive blinking, and 2) Determine the CMOR's sensitivity to changes in symptom severity associated with interventions. To accomplish this, the UCSD researchers will conduct CMOR analyses of motor symptoms from video recordings of 100 blepharospasm patients enrolled in a separate study evaluating the variability of botulinum neurotoxin treatment efficacy. This project aims to provide critical information about the validity of the CMOR system and establish a quantitative basis for sample size estimates in future blepharospasm clinical trials.

Generated 4/8/25, 4:11 AM